On going study - Summary: As part of a EUnetHTA collaboration, this HTA aims at assessing the effectiveness and cost-effectiveness of two gene expression profiling tests (MammaPrint and Oncotype) in identifying those early stage breast cancer patients more likely to benefit from adjuvant chemotherapy.
